Alpine Immune Sciences Inc
ALPN
Market Cap$4.46B
Close$
$37.58
42.2% downside
Current Fair Value
42.2% downsideOvervalued by 42.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.46 Billion |
|---|---|
| Enterprise Value | $4.16 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.68 |
| Beta | 1.54 |
| Outstanding Shares | 68,597,527 |
| Avg 30 Day Volume | 1,904,904 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -120.97 |
|---|---|
| PEG | -344.97 |
| Price to Sales | - |
| Price to Book Ratio | 16.24 |
| Enterprise Value to Revenue | 73.6 |
| Enterprise Value to EBIT | -81.01 |
| Enterprise Value to Net Income | -113 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
ESG Score
No data
About Alpine Immune Sciences Inc
CEO: Mitchell Gold